CLINICAL_TRIALS
trial_result
· 2020-10-30
Clinical Trial Update: To Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With MDD [Phase 1, Phase 2]
Summary
Clinical trial update for Hypidone Hydrochloride Tablets in major depressive disorder, spanning Phase 1 and Phase 2, status completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zhejiang Huahai Pharmaceutical Co., Ltd. | Conditions: Major Depressive Disorder | Phase 1, Phase 2 | Status: COMPLETED